Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OmniLit Acquisition (OLIT) Competitors

OmniLit Acquisition logo

OLIT vs. CLIR, DAIO, MSAI, STAI, PRPO, BNGO, ASTC, TLIS, AXDX, and TBIO

Should you be buying OmniLit Acquisition stock or one of its competitors? The main competitors of OmniLit Acquisition include ClearSign Technologies (CLIR), Data I/O (DAIO), MultiSensor AI (MSAI), ScanTech AI Systems (STAI), Precipio (PRPO), Bionano Genomics (BNGO), Astrotech (ASTC), Talis Biomedical (TLIS), Accelerate Diagnostics (AXDX), and Telesis Bio (TBIO). These companies are all part of the "measuring and control equipment" industry.

OmniLit Acquisition vs. Its Competitors

ClearSign Technologies (NASDAQ:CLIR) and OmniLit Acquisition (NASDAQ:OLIT) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

24.0% of ClearSign Technologies shares are owned by institutional investors. Comparatively, 21.6% of OmniLit Acquisition shares are owned by institutional investors. 5.0% of ClearSign Technologies shares are owned by insiders. Comparatively, 78.0% of OmniLit Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

OmniLit Acquisition has a net margin of 0.00% compared to ClearSign Technologies' net margin of -216.48%. OmniLit Acquisition's return on equity of 0.00% beat ClearSign Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
ClearSign Technologies-216.48% -44.36% -38.35%
OmniLit Acquisition N/A N/A N/A

ClearSign Technologies currently has a consensus target price of $2.00, indicating a potential upside of 243.05%. Given ClearSign Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe ClearSign Technologies is more favorable than OmniLit Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ClearSign Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
OmniLit Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

OmniLit Acquisition has lower revenue, but higher earnings than ClearSign Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ClearSign Technologies$3.60M8.49-$5.30M-$0.12-4.86
OmniLit AcquisitionN/AN/AN/AN/AN/A

ClearSign Technologies has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, OmniLit Acquisition has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

In the previous week, ClearSign Technologies' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
ClearSign Technologies Neutral
OmniLit Acquisition Neutral

Summary

ClearSign Technologies beats OmniLit Acquisition on 6 of the 10 factors compared between the two stocks.

Get OmniLit Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLIT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OLIT vs. The Competition

MetricOmniLit AcquisitionHolding Offices Industry SectorNASDAQ Exchange
Market Cap$8.41M$181.57M$2.01B$9.05B
Dividend YieldN/A5.41%13.71%3.99%
P/E RatioN/A2.4812.1120.23
Price / SalesN/A435.632,026,446.21119.26
Price / CashN/A74.7856.1028.59
Price / BookN/A6.473.755.65
Net IncomeN/A$3.67M-$302.05M$249.15M

OmniLit Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OLIT
OmniLit Acquisition
N/A$1.37
-1.4%
N/A-43.2%$8.41MN/A0.003
CLIR
ClearSign Technologies
1.737 of 5 stars
$0.56
-1.8%
$2.00
+257.3%
-33.8%$29.35M$3.60M-4.6710
DAIO
Data I/O
2.5999 of 5 stars
$3.09
+1.6%
$4.00
+29.4%
+11.8%$28.55M$21.77M-10.66100Positive News
Gap Up
MSAI
MultiSensor AI
2.7425 of 5 stars
$0.55
-10.9%
$2.50
+357.0%
-63.3%$18.29M$7.40M0.0035
STAI
ScanTech AI Systems
N/A$0.66
-1.5%
N/AN/A$16.90M$540K0.00N/AGap Up
PRPO
Precipio
N/A$10.80
-3.9%
N/A+144.0%$16.43M$18.53M-5.2260
BNGO
Bionano Genomics
1.2974 of 5 stars
$3.29
flat
$7.00
+112.8%
-89.7%$11.07M$30.78M-0.02300
ASTC
Astrotech
N/A$5.69
flat
N/A-35.6%$9.64M$1.66M-0.6810Positive News
TLIS
Talis Biomedical
N/A$1.40
-2.1%
N/A-83.9%$2.55M$300K-0.05260Gap Down
AXDX
Accelerate Diagnostics
N/AN/AN/AN/A$857K$11.70M-0.01220Gap Down
High Trading Volume
TBIO
Telesis Bio
N/A$0.30
+200.0%
N/AN/A$541K$225.09M-0.01200Gap Up

Related Companies and Tools


This page (NASDAQ:OLIT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners